Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

May 15, 2017

Conditions
Thoracic Aortic Aneurysmsand Penetrating Atherosclerotic Ulcers
Interventions
DEVICE

Relay Thoracic Stent-Graft

implant

PROCEDURE

Open Repair

Open surgery

Trial Locations (27)

10032

New York Presbyterian Hospital --Columbia/Cornell University, New York

12208

Albany Medical Center, Albany

15213

University of Pittsburgh, Pittsburgh

19104

Hospital of the University of Pennsylvania/Penn Presbyterian, Philadelphia

22042

INOVA Fairfax Hospital, Falls Church

23510

Sentara Heart Hospital, Norfolk

27599

University of North Carolina at Chapel Hill, Chapel Hill

27834

East Carolina University, Greenville

30322

Emory University, Atlanta

32610

University of Florida, Gainesville

33136

University of Miami, Miami

33176

Baptist Cardiac and Vascular Institute, Miami

43210

Ohio State University, Columbus

44195

Cleveland Clinic Foundation, Cleveland

46202

Clarian Cardiovascular, Indianapolis

46250

Indiana Heart Hospial, Indianapolis

48109

University of Michigan, Ann Arbor

53215

Aurora St. Luke's Hospital, Milwaukee

55905

The Mayo Clinic, Rochester

61103

Rockford Memorial Hospital, Rockford

77030

Methodist Hospital, Houston

85006

Arizona Heart Hospital, Phoenix

85724

University of Arizona, Tucson

94143

University of California-San Francisco, San Francisco

98105

University of Washington, Seattle

20010-2975

Washington Hospital Center, Washington D.C.

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bolton Medical

INDUSTRY

NCT00435942 - Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft | Biotech Hunter | Biotech Hunter